Search Results for: NEU1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
GLB1 galactosidase beta 1
  • Glycosphingolipid metabolism
  • Keratan sulfate degradation
  • HS-GAG degradation
  • MPS IV - Morquio syndrome B
  • Sialic acid metabolism
  • Defective NEU1 causes sialidosis
  • Neutrophil degranulation
  • Lactose
  • Galactosialidosis
  • GM1 gangliosidosis
  • Mucopolysaccharidosis type IV (MPS4), including: Morquio syndrome A (MPS4A); Morquio syndrome B (MPS4B)
GOLM1 golgi membrane protein 1
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
GPR152 G protein-coupled receptor 152
GPX8 glutathione peroxidase 8 (putative)
  • Detoxification of Reactive Oxygen Species
  • Glutathione
  • Glutathione disulfide
HSD17B11 hydroxysteroid 17-beta dehydrogenase 11
  • Estrogen biosynthesis
  • Aetiocholanolone
JUNB JunB proto-oncogene, AP-1 transcription factor subunit
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Interleukin-4 and Interleukin-13 signaling
  • NGF-stimulated transcription
  • NGF-stimulated transcription
KCNA2 potassium voltage-gated channel subfamily A member 2
  • Voltage gated Potassium channels
  • Enflurane
  • Promethazine
  • Miconazole
  • Dalfampridine
KCNA4 potassium voltage-gated channel subfamily A member 4
  • Voltage gated Potassium channels
  • Enflurane
  • Promethazine
  • Miconazole
  • Arginineamide
  • Dalfampridine
LIG4 DNA ligase 4
  • 2-LTR circle formation
  • Nonhomologous End-Joining (NHEJ)
  • DNA repair defects, including the following six diseases: Ataxia telangiectasia (AT); Ataxia-talangiectasia-like syndrome; Nijmegen syndrome; DNA ligase I deficiency; DNA ligase IV deficiency; Bloom's syndrome
LMNA lamin A/C
  • XBP1(S) activates chaperone genes
  • Signaling by BRAF and RAF fusions
  • Restrictive dermopathy
  • Emery-Dreifuss muscular dystrophy
  • Dilated cardiomyopathy (DCM)
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
  • Mandibuloacral dysplasia
  • Congenital muscular dystrophies (CMD/MDC), including: Merosin-deficient CMD (MDC1A); Ullrich CMD (UCMD); Integrin alpha7-deficient CMD; CMD with joint hyperlaxity (CMDH); CMD with epidermolysis bullosa; Walker-Warburg syndrome (WWS); Muscle-eye-brain disease (MEB); Fukuyama CMD (FCMD); CMD with muscle hypertrophy (MDC1C); CMD with severe intellectual impairment and abnormal glycosylation (MDC1D); Rigid spine syndrome (RSS); LMNA-deficient CMD; CMD with respiratory failure and muscle hypertrophy (MDC1B); Bethlem myopathy
  • Limb-girdle muscular dystrophy (LGMD)
  • Familial partial lipodystrophy (FPL), including the following four diseases: Kobberling-type lipodystrophy (FPLD1); Dunnigan-type lipodystrophy (FPLD2); Dunnigan-like lipodystrophy (FPLD3); AKT2 associated lipodystrophy
  • Hutchinson-Gilford progeria syndrome
MGST3 microsomal glutathione S-transferase 3
  • Glutathione conjugation
  • Aflatoxin activation and detoxification
  • Glutathione
MUC1 mucin 1, cell surface associated
  • Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)
  • Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)
  • Defective GALNT12 causes colorectal cancer 1 (CRCS1)
  • Dectin-2 family
  • Interleukin-4 and Interleukin-13 signaling
  • O-linked glycosylation of mucins
  • Termination of O-glycan biosynthesis
  • TG4010
SLC10A1 solute carrier family 10 member 1
  • Recycling of bile acids and salts
SLC10A6 solute carrier family 10 member 6
  • Transport of bile salts and organic acids, metal ions and amine compounds
SLC18A1 solute carrier family 18 member A1
  • Na+/Cl- dependent neurotransmitter transporters
  • Reserpine
  • Norepinephrine
  • Ephedra sinica root
  • MMDA
  • Metamfetamine
SLC39A9 solute carrier family 39 member 9
TMEM14B transmembrane protein 14B

Page 2 out of 2 pages